SOPHSOPHiA Genetics SA

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center PR Newswire NEW YORK, June 4, 2026 SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine...

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the...

BTIG Research restated a "buy" rating and set a $8.00 target price on shares of SOPHiA GENETICS in a report on Wednesday...

SOPHiA GENETICS (NASDAQ:SOPH) reported first-quarter 2026 revenue of $21.7 million, up 22% from $17.8 million in the prior-year period, as demand increased for its SOPHiA DDM analytics platform and the company expanded its installed base of clinical customers and applications. Revenue growth and re...

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of...

SOPHiA GENETICS Reports First Quarter 2026 Results SOPHiA GENETICS Reports First Quarter 2026 Results PR Newswire BOSTON and ROLLE, Switzerland, May 5, 2026 BOSTON and ROLLE, Switzerland, May 5, 2026...

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) insider Philippe Menu sold 5,000 shares of the business's stock in a transaction dated Monday, April 27th. The stock was sold at an average price of...

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totaling 175,963 shares, a...